3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 24 0 0 0 0 0 0 0999 V2000
0.5844 3.2746 0.3743 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.8248 1.1698 -0.4168 S 0 0 0 0 0 0 0 0 0 0 0 0
4.7731 0.2070 0.4060 F 0 0 0 0 0 0 0 0 0 0 0 0
3.9890 -1.7196 1.0203 F 0 0 0 0 0 0 0 0 0 0 0 0
4.2897 -1.2943 -1.0909 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.7593 -1.3628 0.3674 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.7786 0.8314 -0.3351 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1175 -0.6253 -0.4710 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4582 -0.2114 -0.0296 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1856 1.1333 0.1959 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1086 0.6881 -0.2445 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8801 1.5997 0.0884 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3986 -1.0419 -0.3572 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8442 -0.7410 0.0763 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6807 -0.3489 0.0648 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1777 -0.1811 -0.0041 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1906 -1.3778 0.3557 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9900 1.8174 0.4549 H 0 0 0 0 0 0 0 0 0 0 0 0
1.5501 -2.1005 -0.5446 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4055 -1.1581 -0.6186 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4033 -0.6086 1.0909 H 0 0 0 0 0 0 0 0 0 0 0 0
-6.5629 -1.1862 -0.6551 H 0 0 0 0 0 0 0 0 0 0 0 0
-6.5826 -0.6374 1.0596 H 0 0 0 0 0 0 0 0 0 0 0 0
-6.5227 -2.3709 0.6697 H 0 0 0 0 0 0 0 0 0 0 0 0
1 12 1 0 0 0 0
2 11 1 0 0 0 0
2 15 1 0 0 0 0
3 14 1 0 0 0 0
4 14 1 0 0 0 0
5 14 1 0 0 0 0
6 16 1 0 0 0 0
6 17 1 0 0 0 0
7 16 2 0 0 0 0
8 11 1 0 0 0 0
8 13 2 0 0 0 0
9 10 2 0 0 0 0
9 13 1 0 0 0 0
9 14 1 0 0 0 0
10 12 1 0 0 0 0
10 18 1 0 0 0 0
11 12 2 0 0 0 0
13 19 1 0 0 0 0
15 16 1 0 0 0 0
15 20 1 0 0 0 0
15 21 1 0 0 0 0
17 22 1 0 0 0 0
17 23 1 0 0 0 0
17 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
methyl 2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanylacetate
4.2 InChl
InChI=1S/C9H7ClF3NO2S/c1-16-7(15)4-17-8-6(10)2-5(3-14-8)9(11,12)13/h2-3H,4H2,1H3
4.3 InChlKey
QVAOQFSVNMEAGO-UHFFFAOYSA-N
4.4 Canonical SMILES
COC(=O)CSC1=C(C=C(C=N1)C(F)(F)F)Cl
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病